Breaks Categories: News

ThursdaySep 07, 2017 1:02 pm

CBDNewsBreaks – Cannabics Pharmaceuticals (CNBX) Files Patent Application for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) has filed an extensive provisional patent application with the U.S. Patent & Trademark Office on a new “Method for Sensitivity Tests of Cannabinoids on Patient Derived Tumor Biopsies and CTCs.” The method, developed by Cannabics Pharmaceuticals, expands the company’s proprietary technology of personalization of cannabinoid medicine. The current invention pertains to a combined method and system for assessing the sensitivity of a variety of cannabinoid-based treatment modalities on patient-derived primary tumor biopsies as well as blood circulating tumor cells (CTC). In the news release, Dr. Moran Grinberg, Cannabics Pharmaceuticals Vice President of Research and Development,…

Continue Reading

ThursdaySep 07, 2017 12:58 pm

CBDNewsBreaks – EVIO, Inc.’s (SGBYD) EVIO Labs Division Enters Cannabis Testing License Agreement in Colorado

EVIO, Inc. (OTCQB: SGBYD) this morning said that its cannabis testing division, EVIO Labs, has entered into an agreement with Phytatech CO, LLC to license its brand and cannabis technology in Colorado. Per the agreement, Phytatech will now operate under the EVIO Labs brand. "As we continue our mission to become the industry’s largest cannabis testing company, with operations in California, Oregon, Massachusetts, and Florida, EVIO is honored to now offer its accredited testing services to Colorado,” EVIO chief executive officer William Waldrop stated in the news release. To view the full press release, visit: http://cnw.fm/UgRy3 About EVIO EVIO, Inc.…

Continue Reading

ThursdaySep 07, 2017 9:31 am

CBDNewsBreaks – ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) Names Barry Fishman as New CEO

ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning announced the appointment of Barry Fishman as its new chief executive officer, effective October 1, 2017. Fishman brings nearly two decades of experience as a business leader to the ABcann team, having most recently served as CEO of international specialty pharmaceutical company Merus Labs. Under his leadership, Merus’s sales and EBITDA grew at a CAGR of greater than 50 percent, leading to the company’s acquisition by Norgine B.V. in July 2017 for total considerations of roughly $342 million. “Barry's proven experience as a CEO of complex, highly-regulated organizations with international operations…

Continue Reading

WednesdaySep 06, 2017 9:41 am

CBDNewsBreaks – SinglePoint, Inc. (SING) Announces Acquisition of Dr. FeelGood

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its acquisition of Dr. FeelGood, a profitable cannabis distribution company headquartered in Phoenix, Arizona. Per the terms of the agreement, SinglePoint will acquire a 51 percent stake in Dr. FeelGood in exchange for cash and stock, allowing SinglePoint to recognize all of the company’s revenue and effectively strengthening its revenue-by-acquisition strategy. “We are very excited for the success of this acquisition,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “The acquisition of Dr. FeelGood is the third acquisition of the year. SinglePoint's revenue has dramatically increased, which through…

Continue Reading

TuesdaySep 05, 2017 12:09 pm

CBDNewsBreaks – Easton Pharmaceuticals, Inc. (EAPH) Marks C$1M Paid toward Alliance Group Partnership Agreement

Easton Pharmaceuticals (OTC: EAPH) this morning said it has advanced C$1 million in payments to Alliance Group pursuant to its previously announced closing agreement with Canada-based 124123 Ontario Inc. (O/A - Alliance Group). In turn, Alliance has executed C$8 million aggregate toward the LOI contract on its 90 acres of zoned industrial land. Easton has now paid a total of C$1 million out of the C$1.3 million required to acquire a 50% stake in 45 acres of agriculturally zoned land north of Toronto, Ontario, Canada, as well as a business to cultivate, produce and facilitate the sale of its production…

Continue Reading

ThursdayAug 31, 2017 9:20 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Announces Clinical Study of High Absorption TurboCBD™ Product

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced the world’s first clinical study on human volunteers of cannabidiol (CBD) within Lexaria’s TurboCBD™ product. The study, which aims to evaluate the effects of TurboCBD™ on both cardiovascular health and cognitive function, will have a double-blind and placebo controlled cross-over design measuring effects after a single dose, as well as seven days of daily dosing, in 24 volunteers. “Lexaria is proud to be advancing our collective knowledge of the benefits of CBD specifically showcasing the benefits of…

Continue Reading

WednesdayAug 30, 2017 10:57 am

CBDNewsBreaks – PotNetwork Holding, Inc. (POTN) Retains PCAOB-Registered East West Accounting Services, LLC to Initiate Audit

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that it has officially retained the auditing services of East West Accounting Services, LLC, a Public Company Accounting Oversight Board (PCAOB) registered CPA firm based in South Florida. Moving forward, East West will review and analyze PotNetwork’s recently announced financial results, providing credible verification of the company’s second quarter and year-to-date operating performance. “We believe that the timing for this action is now,” Gary Blum, chief executive officer of PotNetwork Holding, stated in the news release. “In consideration of the amount of momentum built up over the past 6 months, coupled with…

Continue Reading

TuesdayAug 29, 2017 9:31 am

CBDNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Scheduled to Attend Two Cannabis Conferences in September

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced its plans to attend two cannabis investment conferences in September. The first, the Investorshub International Cannabis Conference, will be held at the JW Marriott in downtown Los Angeles on September 1-2. The second, the Institutional Capital & Cannabis Conference (East), is scheduled to take place on September 7-8 in Miami Beach. This morning’s news release also included an update on the company’s financing activities. Notably, Lexaria has received and executed a notice of conversion related to certain…

Continue Reading

MondayAug 28, 2017 11:02 am

CBDNewsBreaks – Global Payout, Inc. (GOHE) Targeting Cannabis Industry through Launch of Bitcoin Payment Solution

Payment solutions company Global Payout, Inc. (OTC: GOHE) this morning announced that it will incorporate bitcoin as a payment method for retail and wholesale customers in the cannabis industry, providing a solution for the banking issues that currently face legal cannabis businesses. In support of this initiative, the company’s majority-owned subsidiary, MoneyTrac Technology, Inc., will leverage its virtual financial wallet technology to eliminate cash payments for cannabis at retail stores. “Since there is an inability to access commercial banks for merchant bank accounts, we feel it is imperative to focus on currency alternatives such as bitcoin to service cannabis industry…

Continue Reading

MondayAug 28, 2017 9:55 am

CBDNewsBreaks – PotNetwork Holding, Inc. (POTN) Takes Center Stage at Mayweather-McGregor with Sponsorship Deal

PotNetwork Holding, Inc. (OTC: POTN) this morning announced that its wholly-owned subsidiary, Diamond CBD, Inc., was an official sponsor of two contenders at the Mayweather-McGregor Event that took place on August 26. “We want to thank Francisco Fonseca and Steve Cunningham for the opportunity to gain this monumental level of brand exposure,” Gary Blum, chief executive officer of PotNetwork Holding, stated in the news release. “In consideration of what is paid for a 30 second commercial spot, during a comparable sporting event, we believe that this is one of the most exciting opportunities for public exposure that Diamond CBD and…

Continue Reading